Published on Thu Jun 10 2021

Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19]).

Francesco Santoro, Ivan J Núñez-Gil, María C Viana-Llamas, Charbel Maroun Eid, Rodolfo Romero, Inmaculada Fernández Rozas, Alvaro Aparisi, Victor Manuel Becerra-Muñoz, Marcos García Aguado, Jia Huang, Ludovica Maltese, Enrico Cerrato, Emilio Alfonso-Rodriguez, Alex Fernando Castro Mejía, Francisco Marin, Sergio Raposeiras Roubin, Martino Pepe, Victor H Moreno Munguia, Gisela Feltes, Jesus Varas Navas, Bernardo Cortese, Luis Buzón, Cristoph Liebetrau, Raquel Ramos-Martinez, Antonio Fernandez-Ortiz, Vicente Estrada, Natale Daniele Brunetti

No standard therapy, including anticoagulation regimens, is currently recommended for coronavirus disease 2019. Aim of this study was to evaluate the efficacy of anticoAGulation in coronav virus disease 2019 hospitalized patients and its impact on survival.

1
2
2
Abstract

No standard therapy, including anticoagulation regimens, is currently recommended for coronavirus disease 2019. Aim of this study was to evaluate the efficacy of anticoagulation in coronavirus disease 2019 hospitalized patients and its impact on survival.